Syngene Intl.

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE398R01022
NSEID: SYNGENE
BSEID: 539268
View on NSE | View on BSE

INR

407.30

5.85 (1.46%)

BSENSE

Aug 04, 03:30 PM

BSE+NSE Vol: 9.69 lacs

{
  "main_header": {
    "sid": 197397,
    "name": "Syngene Intl.",
    "stock_name": "Syngene Intl.",
    "full_name": "Syngene International Ltd",
    "name_url": "stocks-analysis/syngene-intl",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "407.30",
    "chg": 5.85,
    "chgp": "1.46%",
    "dir": 1,
    "prev_price": "401.45",
    "mcapval": "16,264.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 539268,
    "symbol": "SYNGENE",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE398R01022",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "01:46 AM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": "9.69 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syngene-intl-197397-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Syngene International Ltd Falls 5.15% Amidst Bearish Momentum and Financial Setbacks",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-falls-515-amidst-bearish-momentum-and-financial-setbacks-4132507",
        "imagepath": "",
        "date": "2026-08-02 14:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock opens strong at Rs.413.95 (+1.81%) amid mixed market signals</p>\n                    <p><strong>28 Jul:</strong> Technical momentum shifts to mildly bearish; stock dips to Rs.409.25 (-1.14%)</p>\n                    <p><strong>30 Jul:</strong> Sharp gap down and new 52-week low at Rs.376.9; Q1 FY27 results reveal steep profit decline</p>\n                    <p><strong>31 Jul:</strong> Downgrade to strong sell and average quality; stock closes at Rs.385.65 (-3.31%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.406.60</div></div>\n  ..."
      },
      {
        "title": "Syngene International Ltd Downgraded to Strong Sell Amidst Deteriorating Financial and Technical Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syngene-international-ltd-downgraded-to-strong-sell-amidst-deteriorating-financial-and-technical-metrics-4129632",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyngeneInternat_mojoScore_4129632.png",
        "date": "2026-07-31 08:03:39",
        "description": "Syngene International Ltd has been downgraded from a Sell to a Strong Sell rating as of 30 July 2026, reflecting a marked deterioration across key investment parameters including financial performance, quality metrics, valuation, and technical indicators. The healthcare services company’s recent quarterly results and market trends have raised significant concerns, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Syngene International Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-faces-bearish-momentum-amid-technical-downgrade-4129402",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyngeneInternat_technicaldot_4129402.png",
        "date": "2026-07-31 08:00:26",
        "description": "Syngene International Ltd, a small-cap player in the Healthcare Services sector, has experienced a marked shift in technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade to a Strong Sell by MarketsMOJO, coupled with a 3.58% decline in daily price, underscores growing investor caution amid weakening price action and subdued relative strength."
      },
      {
        "title": "Syngene International Ltd Downgraded to Average Quality Amid Declining Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-downgraded-to-average-quality-amid-declining-fundamentals-4129343",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyngeneInternat_qualitydot_4129343.png",
        "date": "2026-07-31 08:00:05",
        "description": "Syngene International Ltd, a key player in the Healthcare Services sector, has seen its quality rating downgraded from good to average, reflecting a notable deterioration in its business fundamentals. The downgrade comes amid a challenging financial performance marked by declining profitability, subdued growth, and a weakening return profile, raising concerns for investors amid a broader market that has outperformed the stock significantly over the past decade."
      },
      {
        "title": "Are Syngene International Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-syngene-international-ltd-latest-results-good-or-bad-4129024",
        "imagepath": "",
        "date": "2026-07-30 19:18:41",
        "description": "The latest financial results for Syngene International Ltd reveal significant operational challenges and a concerning decline in profitability. In the quarter ending June 2026, the company reported net sales of ₹736 crores, reflecting a year-on-year decline of 15.84% and a sequential drop of 28.99% from the previous quarter. This marks the lowest revenue figure in over two years, indicating potential issues such as client attrition or project delays that have not been effectively addressed.\n\nThe operating profit, excluding other income, fell sharply to ₹90.80 crores, representing a substantial year-on-year decline of 56.01% and a sequential decrease of 70.07%. The operating margin also contracted significantly to 12.34%, the lowest recorded in the past twelve quarters, suggesting severe pressure on cost management and pricing power. This margin compression raises questions about the sustainability of the co..."
      },
      {
        "title": "Syngene International Q1 FY27: Sharp Profit Decline Signals Deepening Operational Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/syngene-international-q1-fy27-sharp-profit-decline-signals-deepening-operational-crisis-4128691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyngeneInternat_quaterlyResult_4128691.png",
        "date": "2026-07-30 09:46:25",
        "description": "Syngene International Ltd., the contract research and manufacturing services provider, reported a staggering loss of ₹9.00 crores for Q1 FY27, marking a dramatic reversal from the ₹86.70 crores profit posted in Q1 FY26. The 110.38% year-on-year decline in profitability, coupled with a 15.84% revenue contraction, has sent the stock tumbling 4.27% to ₹396.00, extending its brutal year-to-date decline to 39.16%. With a market capitalisation of ₹15,985.30 crores, the company now trades at a precarious 47x trailing twelve-month earnings despite deteriorating fundamentals."
      },
      {
        "title": "Syngene International Ltd Falls to 52-Week Low of Rs 376.9 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-falls-to-52-week-low-of-rs3769-amidst-continued-underperformance-4128197",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyngeneInternat_priceRelatedfactors_4128197.png",
        "date": "2026-07-30 09:40:58",
        "description": ""
      },
      {
        "title": "Syngene International Ltd Opens 7.4% Lower in Sharp Gap Down as Technicals Point to Further Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-opens-with-significant-gap-down-amid-market-concerns-4128189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyngeneInternat_gapdown_4128189.png",
        "date": "2026-07-30 09:40:11",
        "description": ""
      },
      {
        "title": "Syngene International Ltd Hits Intraday Low Amid Price Pressure on 30 Jul 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-ltd-hits-intraday-low-amid-price-pressure-on-30-jul-2026-4128156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SyngeneInternat_priceRelatedfactors_4128156.png",
        "date": "2026-07-30 09:31:41",
        "description": "Syngene International Ltd experienced significant intraday weakness on 30 Jul 2026, hitting a new 52-week low of Rs. 377.45 as the stock faced intense selling pressure and underperformed its sector and benchmark indices."
      }
    ],
    "total": 356,
    "sid": "197397",
    "stock_news_url": "https://www.marketsmojo.com/news/syngene-international-197397"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "31-Jul-2026",
      "details": "Scrutinizers Report and voting results of 33rd Annual General Meeting",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "30-Jul-2026",
      "details": "Intimation of audio recording for Q1 FY27 post-earnings call",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Jul-2026",
      "details": "Newspaper Advertisement - Financial Results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syngene International Ltd has declared <strong>12%</strong> dividend, ex-date: 25 Jun 26",
          "dt": "2026-06-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syngene International Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Jun 19",
          "dt": "2019-06-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Syngene International Ltd Falls 5.15% Amidst Bearish Momentum and Financial Setbacks

2026-08-02 14:00:05

Key Events This Week

27 Jul: Stock opens strong at Rs.413.95 (+1.81%) amid mixed market signals

28 Jul: Technical momentum shifts to mildly bearish; stock dips to Rs.409.25 (-1.14%)

30 Jul: Sharp gap down and new 52-week low at Rs.376.9; Q1 FY27 results reveal steep profit decline

31 Jul: Downgrade to strong sell and average quality; stock closes at Rs.385.65 (-3.31%)

Week Open

Rs.406.60

...

Read full news article

Syngene International Ltd Downgraded to Strong Sell Amidst Deteriorating Financial and Technical Metrics

2026-07-31 08:03:39

Syngene International Ltd has been downgraded from a Sell to a Strong Sell rating as of 30 July 2026, reflecting a marked deterioration across key investment parameters including financial performance, quality metrics, valuation, and technical indicators. The healthcare services company’s recent quarterly results and market trends have raised significant concerns, prompting a reassessment of its investment appeal.

Read full news article

Syngene International Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-07-31 08:00:26

Syngene International Ltd, a small-cap player in the Healthcare Services sector, has experienced a marked shift in technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade to a Strong Sell by MarketsMOJO, coupled with a 3.58% decline in daily price, underscores growing investor caution amid weakening price action and subdued relative strength.

Read full news article

Syngene International Ltd Downgraded to Average Quality Amid Declining Fundamentals

2026-07-31 08:00:05

Syngene International Ltd, a key player in the Healthcare Services sector, has seen its quality rating downgraded from good to average, reflecting a notable deterioration in its business fundamentals. The downgrade comes amid a challenging financial performance marked by declining profitability, subdued growth, and a weakening return profile, raising concerns for investors amid a broader market that has outperformed the stock significantly over the past decade.

Read full news article

Are Syngene International Ltd latest results good or bad?

2026-07-30 19:18:41

The latest financial results for Syngene International Ltd reveal significant operational challenges and a concerning decline in profitability. In the quarter ending June 2026, the company reported net sales of ₹736 crores, reflecting a year-on-year decline of 15.84% and a sequential drop of 28.99% from the previous quarter. This marks the lowest revenue figure in over two years, indicating potential issues such as client attrition or project delays that have not been effectively addressed. The operating profit, excluding other income, fell sharply to ₹90.80 crores, representing a substantial year-on-year decline of 56.01% and a sequential decrease of 70.07%. The operating margin also contracted significantly to 12.34%, the lowest recorded in the past twelve quarters, suggesting severe pressure on cost management and pricing power. This margin compression raises questions about the sustainability of the co...

Read full news article

Syngene International Q1 FY27: Sharp Profit Decline Signals Deepening Operational Crisis

2026-07-30 09:46:25

Syngene International Ltd., the contract research and manufacturing services provider, reported a staggering loss of ₹9.00 crores for Q1 FY27, marking a dramatic reversal from the ₹86.70 crores profit posted in Q1 FY26. The 110.38% year-on-year decline in profitability, coupled with a 15.84% revenue contraction, has sent the stock tumbling 4.27% to ₹396.00, extending its brutal year-to-date decline to 39.16%. With a market capitalisation of ₹15,985.30 crores, the company now trades at a precarious 47x trailing twelve-month earnings despite deteriorating fundamentals.

Read full news article

Syngene International Ltd Falls to 52-Week Low of Rs 376.9 as Sell-Off Deepens

2026-07-30 09:40:58

Read full news article

Syngene International Ltd Opens 7.4% Lower in Sharp Gap Down as Technicals Point to Further Weakness

2026-07-30 09:40:11

Read full news article

Syngene International Ltd Hits Intraday Low Amid Price Pressure on 30 Jul 2026

2026-07-30 09:31:41

Syngene International Ltd experienced significant intraday weakness on 30 Jul 2026, hitting a new 52-week low of Rs. 377.45 as the stock faced intense selling pressure and underperformed its sector and benchmark indices.